| Teva Pharma AG - Docetaxel-Teva liquid 140 mg/7 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 60726 | | 03 | | Docetaxel-Teva liquid 140 mg/7 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01CD02 | | Docetaxel | | 21.01.2011 | | |
|
| Composition |
| docetaxelum 140 mg, acidum citricum, povidonum K 12, polysorbatum 80, ethanolum anhydricum q.s. ad solutionem pro 7 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Docetaxel | 140mg / 7ml |
| | BAG: Active Agent | Dose |
|---|
| Docetaxel | 140 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid | | | Ethanol Anhydrate | | | Polysorbatum 80 | | | Povidonum K | 12 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 009 | | 334.01 | 379.65 | A | SL | No |
|
